-

BTIG Announces Plans to Continue Working Remotely Until September 2021

NEW YORK--(BUSINESS WIRE)--BTIG announced today that employees will not be required to return to any of the firm’s U.S. offices prior to Labor Day of 2021. In March 2020, BTIG was one of the first financial services firms to send all of its employees home to work remotely in response to the COVID-19 pandemic. BTIG will continue to evaluate the data on the global health crisis, and make all future reopening and other logistical decisions based upon the latest information available from the medical community and local government officials.

BTIG believes that remote work will continue to offer the best protection to its employees, their families, clients and its business operations. The firm does not anticipate a return to its offices until vaccines are widely available, and when it is confirmed that the newly discovered COVID-19 mutations do not pose any additional risks to employees. Once the firm’s offices fully reopen, BTIG expects approximately 30-50% of its employees will choose to incorporate remote work into their regular schedules.

“As a firm, we are very fortunate to find ourselves in a position where we can choose when to safely reopen our offices for staff. The positive feedback we’ve received from our clients, as well as the high levels of employee engagement thus far, enabled us to extend the period of remote work longer than we anticipated in the summer,” said Jennifer Mermel, Chief Operating Officer of BTIG.

BTIG initially targeted January 2021 for the start of a phased return to its U.S. offices. Their latest decision on a return in September applies to all staff, including members of the Institutional and Outsource Trading teams.

About BTIG

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 650 employees, BTIG, LLC and its affiliates operate out of 18 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities (futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities). The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

Disclaimer: https://www.btig.com/disclaimer. To learn more about BTIG, visit www.btig.com.

Contacts

Jill Gordon
443.668.2055
jgordon@prosek.com

Amanda Gold
212.738.6134
agold@btig.com

BTIG, LLC


Release Versions

Contacts

Jill Gordon
443.668.2055
jgordon@prosek.com

Amanda Gold
212.738.6134
agold@btig.com

More News From BTIG, LLC

BTIG Expands Consumer Staples Research Coverage with the Addition of Owen Bennett

NEW YORK--(BUSINESS WIRE)--BTIG announced today that Owen Bennett has joined the firm as Managing Director and Consumer Staples Analyst, focusing on the tobacco and beverage sectors. "We are thrilled to welcome Owen to BTIG. His extensive expertise in the tobacco space, coupled with deep industry relationships and a differentiated research approach, will enhance our consumer sector coverage and broaden the insights we offer to clients," said Ryan Serwin, CFA, BTIG's Director of Research. "Owen’...

BTIG Announces Strategic Hire for TMT Investment Banking

NEW YORK--(BUSINESS WIRE)--BTIG announced today that Sasson Darwish has joined the firm as a Managing Director and Co-Head of TMT Investment Banking, alongside Brett Fodero and Steven Marder. This hire underscores BTIG’s long-term commitment to growing its Investment Banking practice—particularly within TMT—while continuing to deliver innovative advisory and capital markets solutions to clients. Mr. Darwish brings more than 25 years of investment banking and corporate leadership experience to B...

BTIG to Host 5th Annual Ophthalmology Day on December 1, 2025

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its 5th Annual Ophthalmology Day will take place on Monday, December 1, 2025. The virtual, one-day event will include thematic panel discussions and one-on-one meetings. The event will be hosted by: Ryan Zimmerman, BTIG Medical Technology Analyst Julian Harrison, BTIG Biotechnology Analyst Thomas Shrader, PhD, CFA, BTIG Biotechnology Analyst Justin Zelin, BTIG Biotechnology Analyst Jeet Mukherjee, BTIG Biotechnology Analyst “We are proud to c...
Back to Newsroom